Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jiangxi Zhenshiming Pharmaceutical is a prominent Chinese pharmaceutical company specializing in ophthalmic health and eye care products. Founded in 1968 and headquartered in Fuzhou, Jiangxi, the company is widely recognized for its flagship Zhenshiming brand, which includes medicated eye drops, steam eye masks, and various vision health supplements. Its product portfolio uniquely blends Traditional Chinese Medicine with modern pharmacological techniques to treat conditions such as eye fatigue, myopia, and dry eye syndrome. In 2021, China Resources Sanjiu (CR Sanjiu) acquired a majority stake in the company for approximately 1.89 billion RMB to strengthen its consumer health presence. Zhenshiming maintains a significant market share in the Chinese over-the-counter ophthalmic market and continues to expand into professional eye care services. The company operates large-scale manufacturing facilities that adhere to national Good Manufacturing Practice (GMP) standards.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 珍视明.